Control Bionics Ltd
ASX:CBL
Control Bionics Ltd
ASX:CBL
Price:
0.043 AUD
Market Closed
Updated:
May 4, 2024
Control Bionics Ltd
Operating Income
|
Control Bionics Ltd
Operating Income Peer Comparison
Comparables:
NTI
IPD
C
CYC
COH
EMV
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Control Bionics Ltd
ASX:CBL
|
Operating Income
-AU$5.2m
|
CAGR 3-Years
-73%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
N/A
|
|
|
Neurotech International Ltd
ASX:NTI
|
Operating Income
-AU$7.8m
|
CAGR 3-Years
-82%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
ImpediMed Ltd
ASX:IPD
|
Operating Income
-AU$20.7m
|
CAGR 3-Years
0%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-12%
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Operating Income
-AU$8.6m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-119%
|
CAGR 10-Years
-25%
|
|
|
Cochlear Ltd
ASX:COH
|
Operating Income
AU$491.1m
|
CAGR 3-Years
36%
|
CAGR 5-Years
6%
|
CAGR 10-Years
15%
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Operating Income
-AU$3.8m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
N/A
|
See Also
What is Control Bionics Ltd's Operating Income?
Operating Income
-5.2m
AUD
-5.2m
AUD
Based on the financial report for Jun 30, 2023, Control Bionics Ltd's Operating Income amounts to -5.2m AUD.
What is Control Bionics Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
-40%
-40%
Over the last year, the Operating Income growth was 15%. The average annual Operating Income growth rates for Control Bionics Ltd have been -73% over the past three years , -40% over the past five years .
You don't have any saved screeners yet
